Press release distribution, EDGAR filing, XBRL, regulatory filings

Press release distribution, EDGAR filing, XBRL, regulatory filings


All 24 fighters on the ... Alnylam Announces Publication of APOLLO Phase 3 Clinical Study Results for Investigational RNAi Therapeutic Patisiran in The New England Journal of Medicine )--Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, announced today that the pivotal study results from the APOLLO Phase 3 trial ... )--Regulatory News: Ipsen today announced that The New England Journal of Medicine published results from the CELESTIAL phase 3 pivotal trial... )--Regulatory News: Ipsen a annonc aujourd'hui que le New England Journal of Medicine a publi les rsultats de l'tude pivotale de phase ... )--Exelixis, Inc. today announced that The New England Journal of Medicine published results from the CELESTIAL phase 3 pivotal tria... )--The "India Switchgear Market By Type , By Application , By Enclosure --The "Global Lipstick Market By Product Type , By Distribution ... (more)



from Biotech News